(ciltacabtagene autoleucel)
This information is intended for US patients and caregivers to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended to promote the use of our products, nor to provide medical advice.
CARVYKTI® (ciltacabtagene autoleucel)
Patient Medical Information
What Are the Possible Side Effects of CARVYKTI?
Last Updated: 07/11/2024
Summary
Here is a passage from the CARVYKTI MEDICATION GUIDE that may be helpful in addressing your question:
This information is provided ONLY in response to your request and is not intended as medical advice, to promote the use of our product, or suggest using it in any manner other than as described in the PRESCRIBING INFORMATION. All decisions regarding your medical treatment should be made with your healthcare professional(s). Please contact your healthcare professional(s) to discuss the information in this response.
Please refer to the attached full PRESCRIBING INFORMATION and the PATIENT MEDICATION GUIDE for CARVYKTI.1
References
| 1 | CARVYKTI (ciltacabtagene autoleucel) [Prescribing Information]. Horsham, PA: Janssen Biotech, Inc.;https://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/CARVYKTI-pi.pdf. |